Back to state act
Description
On 6 November 2025, the U.S. Administration announced reaching an agreement with Novo Nordisk. Under the agreement, Novo Nordisk will be exempt from future Section 232 tariffs on pharmaceutical produc...
Sign in to see full description
Intervention Details
Intervention Type
Tax or social insurance relief
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
No implementation date
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 3 products
Threads
See all
This intervention is not part of any Thread yet.